SSA
REPL icon

Schonfeld Strategic Advisors’s Replimune Group REPL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,220
Closed -$342K – 2592
2025
Q4 		$342K Buy
+35,220
New +$299K ﹤0.01% 1529
2025
Q3 		– Sell
-234,806
Closed -$2.18M – 2512
2025
Q2 		$2.18M Sell
234,806
-223,866
-49% -$1.95M 0.01% 930
2025
Q1 		$4.47M Buy
458,672
+295,372
+181% +$3.66M 0.03% 562
2024
Q4 		$1.98M Sell
163,300
-408,927
-71% -$4.97M 0.01% 839
2024
Q3 		$6.27M Sell
572,227
-409,008
-42% -$4.15M 0.04% 458
2024
Q2 		$8.83M Buy
981,235
+822,944
+520% +$5.74M 0.06% 385
2024
Q1 		$1.29M Buy
158,291
+115,897
+273% +$950K 0.01% 1133
2023
Q4 		$357K Buy
+42,394
New +$492K ﹤0.01% 1380

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Schonfeld Strategic Advisors's REPL Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 35,220 shares — an estimated $342K sold.

Schonfeld Strategic Advisors first reported a position in REPL in Q4 2023 and held it in 8 quarters. The position peaked at $8.83M in Q2 2024. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 35,220 Replimune Group shares in Q1 2026, an estimated $342K.
  • Schonfeld Strategic Advisors first reported a position in Replimune Group in Q4 2023 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's Replimune Group position peaked at $8.83M in Q2 2024.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.